The US health authorities authorized the booster of the Pfizer vaccine for adolescents between 12 and 15 years of age. They reduced the time before injecting this third dose for all ages from six to five months.
Officials decided during a covid-19 outbreak due to the omicron variant. And when school children are preparing to back to classes after the end of the year holidays.
The US Food and Drug Administration-FDA also approved the ‘Pfizer-BioNTech vaccine’ as a booster dose for immunodeficient children aged 5 to 11. For example, for those who have obtained an organ transplant.
The decision has yet to be endorsed by the Centers for Disease Prevention and Control (CDC).
The FDA claims to rely on data from Israel, where thousands of children and adolescents aged between 12 and 15 have already received the booster dose of Pfizer-BioNTech vaccine and other COVID vaccines after their officials approved and insisted on a booster dose.
The FDA said that more than 4.1 million people from 16 years to older age who received a booster in that country five months after the first two doses had not registered any new safety problems.
The agency wrote in a statement that authorizing vaccination with a booster after five months instead of six may provide better protection against the highly contagious variant of omicron.
It also specified that it concerns the cases of other vaccines.
According to figures from Johns Hopkins University, the United States currently has an average of about 400,000 new Covid-19 cases every day, a record since the beginning of the pandemic.
Hospitalizations are also increasing, despite remaining below the peak recorded a year ago. The income of children suffering from covid-19 also raises.
The Secretary of Education of the United States, Miguel Cardona, said that they are aware that there may be difficulties returning to the classroom. However, the authorities want the schools to keep open as possible. The goal is to keep regular in-class learning because students have already suffered enough.